Bacillus Calmette-Guérin vaccination and infant mortality (Q34512747)

2 August 2017

1 reference

title

Bacillus Calmette-Guérin vaccination and infant mortality (English)

1 reference

2 August 2017

0 references

P Aaby

5

0 references

author name string

Adam Roth

1

1 reference

2 August 2017

M L Garly

2

1 reference

2 August 2017

H Jensen

3

1 reference

2 August 2017

J Nielsen

4

1 reference

2 August 2017

publication date

1 April 2006

1 reference

Expert Review of Vaccines

2 August 2017

published in

1 reference

2 August 2017

volume

5

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

277-293

1 reference

Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Child mortality following standard, medium or high titre measles immunization in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Routine vaccinations and child survival in a war situation with high mortality: effect of gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Field trials of tuberculosis vaccines: how could we have done them better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Tuberculin response two years after BCG vaccination at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Non-specific effects of vaccination: survival bias may explain findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

DTP in low income countries: improved child survival or survival bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Non-specific effects of vaccination on child survival? A prospective study in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Childhood mortality among users and non-users of primary health care in a rural west African community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

BCG vaccination scar associated with better childhood survival in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Tuberculin reactions in malnourished children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Tuberculin response in preterm infants after BCG vaccination at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Low mortality after mild measles infection compared to uninfected children in rural west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Vaccination strategies to reduce the risk of leukaemia and melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Does childhood immunization against infectious diseases protect from the development of atopic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

BCG vaccination and risk of atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Early BCG vaccination and reduction in atopy in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Lower Hookworm Incidence, Prevalence, and Intensity of Infection in Children with a Bacillus Calmette‐Guérin Vaccination Scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Inverse association between BCG immunisation and intestinal nematode infestation among HIV-1-positive individuals in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Patterns of helminth infection and relationship to BCG vaccination in Karonga District, northern Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Heterologous immunity and the nonspecific effects of vaccines: a major medical advance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Vaccines for tuberculosis: novel concepts and recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Recent developments in tuberculosis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Age at bacille Calmette-Guerin vaccination and risk of allergy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.277

21 January 2018

Identifiers

DOI

10.1586/14760584.5.2.277

1 reference

2 August 2017

1 reference